A 62-Year-Old Woman With Metastatic BRAF V600E-Mutated NSCLC
EP. 1: A 62-Year-Old Woman With BRAF V600E+ Metastatic NSCLC
Watch
EP. 2: Impact of Next-Generation Sequencing for Treating mNSCLC
EP. 3: Dabrafenib Plus Trametinib for the Treatment of mNSCLC
EP. 4: Progression of BRAF V600E+ Metastatic NSCLC
EP. 5: Progress Made in Treating BRAF V600E+ Metastatic NSCLC
